Partnerre Ltd's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Partnerre Ltd (PREJ) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Partnerre Ltd vs Its Competitors
- TTM: Trailing 12-month revenue of 9,123M vs 1,155,196M combined for its competitors (0.8% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months), vs decelerating (-12.0%) for its tracked peer group.
- Growth: Partnerre Ltd generated 59.3% revenue growth year over year in Q4 2023, vs 15.5% for its competitors combined.
- Profitability: Its 25.4% net margin compares with 20.1% for the peer group.
- Peer revenue share: Partnerre Ltd accounted for 3.5% of combined revenue among its tracked peer group, up from 2.5% a year earlier.
- Peer differentiation: Revenue per employee of $9.12M compares with $1.30M for the peer group (7.0x).
- Structure: Partnerre Ltd operates in the following segments: Property and Casualty, Life and Health, Specialty.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
PREJ Sales vs. its Competitors, Q4 2023
Partnerre Ltd reported revenue growth of 59.30 % year on year in Q4 2023, above its competitors' combined revenue growth of 15.46 %.
With a net margin of 25.41 %, Partnerre Ltd achieved higher profitability than its competitors (20.08 %).
Partnerre Ltd generated 3.47 % of the combined sales of its peer group, up from 2.54 % a year earlier.
API endpoints for this dataset
Partnerre Ltd vs. its Competitors, Q4 2023
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in Partnerre Ltd reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Partnerre Ltd and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Partnerre Ltd | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (5) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (6) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Partnerre Ltd's competitor groups requires a Commercial License.
For context: the Accident & Health Insurance industry grew revenue 6.5% year over year, combined, vs 59.3% for Partnerre Ltd. Partnerre Ltd's share of combined industry revenue moved from 1.60% to 2.39%, a gain of 0.79 percentage points.
Partnerre Ltd's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Partnerre Ltd | Yes | Yes | Yes | No |
| Competitors combined (55) | ||||
| High-Confidence Competitors (6) | ||||
| Similar Growth & Profitability (8) | 87.50 % (7 of 8) | 100.00 % (8 of 8) | 100.00 % (8 of 8) | 0.00 % (0 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
PREJ Stock Performance relative to its Competitors
PREJ Stock Performance relative to High-Confidence Competitors
PREJ Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Siriuspoint Ltd | 282.9% | Outperformed |
| 2 | Reinsurance Group Of America Incorporated | 282.9% | Outperformed |
| 3 | Voya Financial Inc | 282.9% | Outperformed |
| 4 | Cno Financial Group Inc | 282.9% | Outperformed |
| 5 | Principal Financial Group inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Partnerre Ltd's best-performing competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Partnerre Ltd's Comment on Competition and Industry Peers
Publicly Traded Peers of Partnerre Ltd
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Partnerre Ltd |
- | 9,122.84 |
 Marsh and Mclennan Companies Inc |
98,108.78 | 28,470.00 |
 The Cigna Group |
77,496.60 | 282,382.00 |
 Aon Plc |
71,314.53 | 17,707.00 |
 Metlife Inc |
63,570.86 | 79,403.00 |
 Aflac Incorporated |
62,722.01 | 18,069.00 |
| SUBTOTAL | 811,656.88 | 1,180,684.49 |
Sign in to see all competitors of Partnerre Ltd .
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Partnerre Ltd versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Partnerre Ltd's Competitors Named by the Company
Competitive relationships identified from Partnerre Ltd reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Arch Capital Group Ltd | Company report | 85% |
| Hannover Re | Company report | 85% |
| Swiss Re | Company report | 85% |
| Everest Re | Company report | 85% |
| RGA | Company report | 85% |
| Munich Re | Company report | 85% |
| Transatlantic | Company report | 85% |
| GenRe | Company report | 85% |
| SCOR SE | Company report | 85% |
| RenRe | Company report | 85% |
| Renaissancere Holdings Ltd | Company report | 85% |
| Oxbridge Re Holdings Limited | Company report | 85% |
| Greenlight Capital Re Ltd | Company report | 85% |
| Cno Financial Group Inc | Company report | 85% |
| Enstar Group Ltd | Company report | 85% |
| Maiden Holdings Ltd | Company report | 85% |
| Hartford Financial Services Group Inc | Company report | 85% |
| Alleghany Corp | Company report | 85% |
| Markel Group Inc | Company report | 85% |
| Metlife Inc | Company report | 85% |
| Siriuspoint Ltd | Company report | 85% |
| Cincinnati Financial Corporation | Company report | 85% |
| Atlantic American Corp | Company report | 85% |
| First Trinity Financial Corporation | Company report | 85% |
| Aspen Insurance Holdings Limited | Company report | 85% |
| Utg Inc | Company report | 85% |
| Marsh and Mclennan Companies Inc | Company report | 85% |
| Lincoln National Corporation | Company report | 85% |
| Berkshire Hathaway Inc | Company report | 85% |
| National Western Life Group Inc | Company report | 85% |
| Prudential Financial Inc | Company report | 85% |
| Genworth Financial Inc | Company report | 85% |
| Amerinst Insurance Group Ltd | Company report | 85% |
| Midwest Holding Inc | Company report | 85% |
| American International Group Inc | Company report | 85% |
| The Hartford Insurance Group Inc | Company report | 85% |
| Aon Plc | Company report | 85% |
| Fbl Financial Group Inc | Company report | 85% |
| Aflac Incorporated | Company report | 85% |
| Security National Financial Corporation | Company report | 85% |
| Essent Group Ltd | Company report | 85% |
| Principal Financial Group inc | Company report | 85% |
| Mbia Inc | Company report | 85% |
| Citizens Inc | Company report | 85% |
| National Security Group Inc. | Company report | 85% |
| Axis Capital Holdings Limited | Company report | 85% |
Company report basis, confidence, active dates and source counts for Partnerre Ltd's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
Partnerre Ltd's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Partnerre Ltd | Property and Casualty 43.25 % |
| Marsh and Mclennan Companies Inc | Risk 55.31 % |
| The Cigna Group | Evernorth 86.55 % |
| Aon Plc | Risk Capital 65.40 % |
| Metlife Inc | Group Benefits 33.54 % |
| Aflac Incorporated | Aflac Japan 65.91 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Partnerre Ltd's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Partnerre Ltd | - | 9,122,836 | 2,318,119 |
| Marsh and Mclennan Companies Inc | 98,109 | 299,684 | 43,358 |
| The Cigna Group | 77,497 | 4,171,078 | 102,555 |
| Aon Plc | 71,315 | 295,117 | 65,750 |
| Metlife Inc | 63,571 | 1,726,152 | 79,543 |
| Aflac Incorporated | 62,722 | 1,420,966 | 382,353 |
| PEERS TOTAL | 811,657 | 1,296,883 | 170,881 |
Partnerre Ltd's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent report. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Aon Plc | Europe, Middle East, and Africa, Other Than United Kingdom and Ireland 14.78 % |
| Planet Labs Pbc | North America 42.93 % |
| Blacksky Technology Inc | United States 50.38 % |
| Citizens Inc | All Countries 66.88 % |
Source: revenue geography as reported in each company's reports (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Partnerre Ltd's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Accident & Health Insurance industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (23 companies). See the full Accident & Health Insurance industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 14.97 % | 29.45 % (avg) | -14.5 pp |
| Operating Margin | 28.16 % | industry median | +23.2 pp |
| EBITDA Margin | 22.53 % | 6.03 % (avg) | +16.5 pp |
| Capital Intensity (Capex / Revenue) | 0.00 % | 0.39 % (avg) | -0.4 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Partnerre Ltd's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth | -17.04 % | 300.55 % | -1.49 % | 40.88 % | - | 0.46 % | -22.60 % | 59.30 % |
| Operating Margin | 21.39 % | 12.14 % | 2.23 % | 18.87 % | 9.02 % | 15.13 % | -9.95 % | 28.16 % |
| Return on Invested Capital | 1.56 % | 3.58 % | 0.72 % | 7.66 % | 3.39 % | 5.08 % | -1.68 % | 6.56 % |
| P/E | - | - | - | - | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Partnerre Ltd's Strategic Group Map
Partnerre Ltd is shown in red; its closest peers by combined growth, margin and ROIC are labeled. See Methodology: Strategic Group Map for how this chart is built.
Partnerre Ltd's trailing-12-month revenue growth of 59.3% and operating margin of 28.2% compares with an average of 32.5% growth and 16.7% margin across its 8 closest peers by combined growth, margin and ROIC -- Partnerre Ltd sits above that peer average on growth and above it on margin.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Partnerre Ltd's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Barriers to Entry | Lower than typical for the industry | Capital intensity (capex / revenue) of 0.00 % vs industry average 0.39 % (see Profitability & Cost Structure above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Partnerre Ltd's dedicated Suppliers and Customers pages, not here.
Partnerre Ltd's Industry Attractiveness & Competitive Strength
See Methodology: GE/McKinsey Matrix for how the two axes are built.
Partnerre Ltd falls in the Low attractiveness / High strength cell: Selective.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Partnerre Ltd's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Operating margin 23.2 points above the industry median.
- Return on equity 9.3 points above the industry aggregate.
- Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months).
Weaknesses
No rule matched.
Opportunities
No rule matched.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-12.0% annualized).
Methodology: see Methodology: SWOT Analysis.
Partnerre Ltd's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Partnerre Ltd | 0.01 | 0.27 | 0.22 |
| Marsh and Mclennan Companies Inc | 0.52 | 1.13 | 1.36 |
| The Cigna Group | 0.12 | 0.82 | 0.76 |
| Aon Plc | 0.06 | 1.06 | 1.86 |
| Metlife Inc | 0.08 | 0.29 | 0.70 |
| Aflac Incorporated | 0.08 | 2.34 | 0.28 |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Partnerre Ltd's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Partnerre Ltd | Q4 2023 | +59.3 % | - |
| Marsh and Mclennan Companies Inc | Q3 2026 | +7.9 % | +6.7 % |
| The Cigna Group | Q2 2026 | +6.7 % | +22.4 % |
| Aon Plc | Q3 2026 | +2.6 % | +1.3 % |
| Metlife Inc | Q2 2026 | +10.5 % | +6.0 % |
| Aflac Incorporated | Q2 2026 | -1.0 % | +37.7 % |
| PEERS TOTAL | +7.5 % | +50.6 % |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Partnerre Ltd's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Partnerre Ltd | Q4 2023 | +1.7 % | - |
| Marsh and Mclennan Companies Inc | Q3 2026 | - | +12.5 % |
| The Cigna Group | Q2 2026 | +6.4 % | - |
| Aon Plc | Q3 2026 | - | +36.2 % |
| Metlife Inc | Q2 2026 | +1,959.3 % | - |
| Aflac Incorporated | Q2 2026 | +5.7 % | - |
Partnerre Ltd's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Partnerre Ltd | 7.60% | 7.55% | 27.52% |
| Marsh and Mclennan Companies Inc | 6.96% | 11.21% | 27.25% |
| The Cigna Group | 4.44% | 6.84% | 16.41% |
| Aon Plc | 7.15% | 9.96% | 40.15% |
| Metlife Inc | 0.49% | 0.77% | 12.93% |
| Aflac Incorporated | 4.13% | 9.64% | 16.42% |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Partnerre Ltd's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Partnerre Ltd | - | - |
| Marsh and Mclennan Companies Inc | 24.62 | 3.45 |
| The Cigna Group | 12.45 | 0.27 |
| Aon Plc | 18.55 | 4.03 |
| Metlife Inc | 18.86 | 0.80 |
| Aflac Incorporated | 13.38 | 3.47 |
| PEERS AVERAGE | 5.18 | 0.69 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.